When executing a PT 141 purchase for laboratory evaluation, obtaining analytical-grade Bremelanotide with verified sequence identity and high purity is essential for reproducible data. PX1 Research supplies USA-manufactured PT-141 featuring lot-specific RP-HPLC purity reports, mass spectrometry identification, and low endotoxin profiles for controlled preclinical applications.
When executing a PT 141 purchase for laboratory evaluation, obtaining analytical-grade Bremelanotide with verified sequence identity and high purity is essential for reproducible data. PX1 Research supplies USA-manufactured PT-141 featuring lot-specific RP-HPLC purity reports, mass spectrometry identification, and low endotoxin profiles for controlled preclinical applications.
Securing reliable reagents for peptide research requires strict adherence to analytical verification standards. Researchers initiating a PT-141 purchase must verify that candidate materials meet stringent purity metrics before introduction into in vitro or in vivo model systems. Synthetic peptides produced without rigorous quality controls frequently contain residual truncated sequences, counter-ion impurities, or unreacted reagents that introduce significant noise into binding assays and signaling data.
PX1 Research provides laboratory-grade synthetic peptides designed explicitly for scientific evaluation. By maintaining domestic US manufacturing operations in facilities adhering to Good Manufacturing Practice (GMP) standards, PX1 Research eliminates supply chain ambiguities. Every lot of PT-141 undergo exhaustive testing at independent ISO 17025 accredited laboratories to ensure sequence integrity, high chemical purity, and low background endotoxin levels. Scientists exploring the catalog of all research peptides can rely on consistent lot-to-lot stability.
PT-141, chemically designated as Bremelanotide, is a synthetic cyclic heptapeptide analog of the naturally occurring endogenous neuropeptide alpha-melanocyte-stimulating hormone (α-MSH). Its primary amino acid sequence is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, featuring a molecular mass of approximately 1024.18 Da. The structural stability of the compound is primarily conferred by a lactam bridge formed between the side chains of the aspartic acid and lysine residues, which severely constrains the peptide backbone into a bioactive conformation.
Unlike linear peptides that undergo rapid enzymatic degradation by circulating carboxypeptidases and endopeptidases, the cyclic structure of PT-141 provides enhanced metabolic stability during preclinical assays. This constrained conformation enhances its selectivity for central melanocortin receptor subtypes compared to unconstrained native fragments. Understanding these chemical parameters is crucial when determining solubilization strategies and assay conditions during benchtop experimental design.
The primary mechanism of action of PT-141 involves non-selective, high-affinity agonism across specific members of the G-protein coupled melanocortin receptor (MCR) family. Preclinical binding studies indicate that Bremelanotide binds predominantly to the melanocortin-3 receptor (MC3R) and melanocortin-4 receptor (MC4R) in central nervous system structures, while demonstrating lower activity at MC1R and minimal interaction with MC2R or MC5R.
Activation of MC3R and MC4R initiates intracellular downstream cascades via Gs-protein coupling, stimulating adenylyl cyclase activity and raising cyclic adenosine monophosphate (cAMP) levels. In central neuroendocrine research, this signaling cascade modulates downstream neurotransmitter release, including dopamine, oxytocin, and norepinephrine pathways within the hypothalamus. Investigating these receptor-ligand dynamics offers critical insights into how central melanocortin signaling regulates autonomic functions independently of peripheral vascular mechanisms.
A substantial body of preclinical literature documents the involvement of central melanocortin signaling in modulating complex behavioral and physiological responses. Rodent models utilizing microinfusions of PT-141 into specific brain regions—such as the medial preoptic area (mPOA) and the paraventricular nucleus (PVN) of the hypothalamus—have demonstrated significant increases in appetitive and consummatory sexual behavior parameters. Preclinical studies suggest these responses are mediated through central neural networks rather than direct peripheral vasodilation.
Further investigation in non-human primate models confirmed that central MC4R activation downstream of Bremelanotide administration modulates neuroendocrine pathways linked to sexual motivation and arousal responses. In vitro ligand-binding assays continue to utilize PT-141 to map out GPCR receptor desensitization, beta-arrestin recruitment, and receptor trafficking kinetics in transfected cell lines, solidifying its utility across various neurobiology research paradigms.
To properly contextualize data derived from a PT-141 purchase, researchers often contrast its activity against other melanocortin receptor agonists. For example, while Melanotan II functions as a potent non-selective melanocortin agonist with significant activity at MC1R, PT-141 was structurally refined to exhibit lower affinity for MC1R, thereby reducing melanogenic stimulation in favor of central neurological targets.
Compared to endogenous signaling molecules such as Alpha-MSH, PT-141 offers markedly increased resistance to enzymatic cleavage, allowing for extended receptor occupancy in cellular and animal models. Similarly, comparing PT-141 to compounds like Afamelanotide demonstrates clear differences in tissue selectivity: Afamelanotide is tailored for peripheral cutaneous MC1R binding, whereas PT-141 serves as the primary tool for central MC3R/MC4R axis evaluation. Understanding these distinctions helps research teams select the optimal control compounds for their specific experimental assays.
Verifying material quality prior to experimental initiation is a foundational requirement for rigorous science. Every batch of PT-141 supplied by PX1 Research undergoes reverse-phase high-performance liquid chromatography (RP-HPLC) to establish chemical purity. The resulting chromatograms confirm that overall purity consistently meets or exceeds 98%, with minimal baseline drift or unresolved secondary peaks.
In addition to RP-HPLC, electrospray ionization mass spectrometry (ESI-MS) is performed to confirm exact molecular mass and sequence fidelity, ruling out amino acid substitutions or incomplete chain assembly. Crucially, PX1 Research subjects all peptide lots to chromogenic Limulus Amebocyte Lysate (LAL) testing to quantify bacterial endotoxin levels. Securing reagents with verified low endotoxin levels (<0.01 EU/mg) prevents confounding inflammatory cytokine activation in cell culture assays or animal models.
Proper handling of lyophilized PT-141 is vital to preserve peptide integrity and prevent premature enzymatic or hydrolytic degradation. Upon receipt, the sealed vial containing lyophilized peptide cake should be stored in a controlled temperature environment at -20°C for short-term preservation or -80°C for long-term storage. Vials should be allowed to equilibrate to room temperature prior to opening to prevent atmospheric moisture condensation on the cake.
Reconstitution should be performed using sterile laboratory-grade solvents, such as bacteriostatic water or sterile phosphate-buffered saline (PBS), depending on the requirements of the planned assay. Gentle swirling without vortexing is recommended to solubilize the powder completely, as vigorous mechanical shear stress can disrupt delicate secondary structures or promote aggregation. Once reconstituted, stock solutions should be divided into single-use aliquots and maintained at -20°C to avoid repeated freeze-thaw cycles that compromise peptide potency.
Institutional laboratories requiring scalable supply chains for longitudinal studies benefit from direct manufacturer relationships. PX1 Research maintains state-of-the-art dispatch hubs in California and Arizona, providing rapid, same-day shipping for orders placed Monday through Friday. This domestic infrastructure minimizes transit times and thermal exposure, preserving raw material quality upon arrival at institutional receiving facilities.
For research groups executing large-scale screen series or long-term animal models, PX1 Research provides specialized procurement options through our wholesale laboratory account program. Purchasing directly from a verified US manufacturer guarantees lot-to-lot traceability, transparent documentation, and direct access to comprehensive analytical records. Researchers can access our extensive peptide research library to review technical documentation and mechanistic data across our portfolio.
What purity level is verified for a PT 141 purchase from PX1 Research?
Every lot of PT-141 from PX1 Research is verified via RP-HPLC to guarantee chemical purity of 98% or higher. A lot-specific Certificate of Analysis (COA) detailing HPLC chromatograms and mass spectrometry identification is included with each shipment.
Is PT-141 supplied by PX1 Research intended for human consumption?
No. All products offered by PX1 Research, including PT-141, are strictly manufactured for in vitro, benchtop, and preclinical laboratory research use only. They are not intended for human or animal therapeutic, diagnostic, or clinical applications.
How should lyophilized PT-141 be stored upon delivery?
Lyophilized PT-141 should be stored at -20°C upon receipt for standard laboratory holding times, or at -80°C for extended archival storage. Ensure the product container remains tightly sealed to protect against humidity.
What diluents are recommended for reconstituting PT-141 in a lab setting?
Common reconstitution media include sterile bacteriostatic water, sterile 0.9% saline, or laboratory-grade phosphate-buffered saline (PBS), depending on downstream experimental compatibility and target concentration requirements.
How does PX1 Research test for endotoxins in PT-141 lots?
PX1 Research utilizes kinetic chromogenic Limulus Amebocyte Lysate (LAL) assays performed in ISO 17025 accredited testing facilities to ensure endotoxin levels remain below standard analytical thresholds (<0.01 EU/mg).
What is the primary operational difference between PT-141 and Melanotan II?
While both target melanocortin receptors, PT-141 (Bremelanotide) exhibits selectivity primarily for central MC3R and MC4R pathways, whereas Melanotan II exhibits robust activity at cutaneous MC1R receptors in addition to central subtypes.
Where does PX1 Research ship PT-141 orders from?
All orders are fulfilled directly from domestic US warehouses located in California and Arizona, offering same-day dispatch Monday through Friday to ensure optimal supply chain stability.
How can institutional facilities establish bulk procurement accounts for PT-141?
Academic and commercial research institutions can establish high-volume procurement arrangements by submitting an application through the PX1 Research wholesale portal.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.